Medicated Balm Recalled for Manufacturing Process Deviations
Ecometics, Inc. is voluntarily recalling Vencedor medicated balm (capsaicin 0.028%) nationwide due to manufacturing process deviations. The recall affects Lot #2E021A with expiration date January 2025.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall initiated voluntarily by the firm due to manufacturing process deviations with no reported illnesses or injuries. This falls within the rubric category of voluntary precautionary recalls, which are classified as Moderate severity.
Plain-English summary
Ecometics, Inc., in cooperation with The Larkspur Group Inc., is voluntarily recalling Vencedor medicated balm, a topical product containing 0.028% capsaicin supplied in 1.5 oz. (43g) tubes. The recall encompasses 4,210 units.
The recall was initiated due to Current Good Manufacturing Practices (CGMP) deviations discovered in the manufacturing process. The FDA classified this as a Class II recall. No illnesses or injuries have been reported in association with this product.
The affected product was distributed nationwide throughout the United States. The recalled product is identified by Lot #2E021A with an expiration date of January 2025.
The recalled product
- Product
- Vencedor medicated balm (capsaicin 0.028%) 1.5 oz. (43g) tubes, Distributed by: The Larkspur Group Inc. Norwalk, CT 06854
- Manufacturer
- Ecometics, Inc.
- Category
- Drug — Topical Medicated Balm
- Hazard
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 2E021A
- Exp. Date Jan-25
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27